Company
Vanqua Bio
Vanquishing Neurodegeneration
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2019
- Legal name
- Vanqua Bio
- vanquabio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Founded in 2019, Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases.
Funding snapshot
- Total raised
- $136MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $45M2024-02-15
Funding rounds
- Round, 2024
- $45M2024-02-15, SEC form D sold, 12 investors
- Round, 2021
- $85M2021-08-27, SEC form D sold, 11 investors
- Round, 2019
- $6M2019-09-20, SEC form D sold, 1 investor
About the company
- Status notes
- clinical-stage biopharmaceutical company
Loading relationship preview